BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
©The Author(s) 2025.
World J Clin Oncol. Dec 24, 2025; 16(12): 112443
Published online Dec 24, 2025. doi: 10.5306/wjco.v16.i12.112443
Figure 3
Figure 3 Overall survival stratified by tumor group (uterus vs other) and timing of peritoneal metastases (synchronous vs metachronous), excluding breast cancer. A survival trend favoring metachronous disease was observed in uterine tumors. OS: Overall survival; Sync: Synchronous; Meta: Metachronous.


Write to the Help Desk